Holen Sie sich die Stockscreener-App
1.43
2.88%
0.04
Handel nachbörslich:
1.39
-0.04
-2.80%
Finanzdaten der Acrivon Therapeutics Inc-Aktie (ACRV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
16.08%
17.67
|
21.05 | 16.14 | 15.52 | 14.39 |
| Operating Income/Loss |
16.08%
-17.67
|
-21.05 | -16.14 | -15.52 | -14.39 |
| Nonoperating Income/Loss |
1.182
|
- | 1.671 | 1.606 | 1.637 |
| Income/Loss From Continuing Operations Before Tax |
14.37%
-16.49
|
-19.25 | -14.47 | -13.91 | -12.76 |
| Income/Loss From Continuing Operations After Tax |
14.37%
-16.49
|
-19.25 | -14.47 | -13.91 | -12.76 |
|
Net Income/Loss
|
14.37%
-16.49
|
-19.25 | -14.47 | -13.91 | -12.76 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
25,962%
22.59
|
0.0867 | 22.08 | 21.97 | 21.92 |
| Diluted Average Shares |
25,962%
22.59
|
0.0867 | 22.08 | 21.97 | 21.92 |
| Basic Earnings Per Share |
16.09%
-0.73
|
-0.87 | -0.66 | -0.63 | -0.58 |
| Diluted Earnings Per Share |
16.09%
-0.73
|
-0.87 | -0.66 | -0.63 | -0.58 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):